Ken Griffin Exagen Inc. Put Options Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$1.74 - $3.42 $348 - $684	200 Added 100.0%	400 $1,000
Q2 2024 Aug 14, 2024	SELL	$1.36 - $2.05 $5,304 - $7,994	-3,900 Reduced 95.12%	200 $0
Q1 2024 May 15, 2024	BUY	$1.42 - $2.3 $5,538 - $8,970	3,900 Added 1950.0%	4,100 $6,000
Q4 2023 Feb 14, 2024	BUY	$1.45 - $2.39 $290 - $478	200 New	200 $0
Q1 2023 May 15, 2023	BUY	$2.23 - $2.9 $16,056 - $20,880	7,200 New	7,200 $17,000

6.41M

4.5K

400

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $76.6M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.